trial

The decision to cancel the state witness agreement stems from contradictions between the evidence he gave in trial and the evidence he gave when questioned by police. …

hapabapa/iStock Editorial via Getty Images Bristol Myers Squibb (NYSE:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired as part of its recent Karuna Therapeutics buyout, indicated a well-tolerated…

According to a Friday report by Bloomberg, a  United States jury found Terraform Labs and its co-founder Do Kwon liable for civil fraud over the crash of the Terra ecosystem in 2022. This development comes as Do Kwon continues to…

The UK is gearing up to trial its first electric flying taxis by 2026, a move that could see these futuristic modes of transport in regular use by the end of the decade, according to government sources.Unveiled on Monday, the Future of…

© Reuters. British entrepreneur Mike Lynch arrives at Westminster Magistrates Court in London, Britain, February 12, 2021. REUTERS/Toby Melville/File Photo By Greg Bensinger and Jody Godoy (Reuters) -Mike Lynch, the wealthy tech…

Ilya Lichtenstein, the man behind the looting of billions of dollars from Bitfinex,  is now helping federal prosecutors build a case against Bitcoin Fog, a crypto mixing service. Lichtenstein pleaded guilty to money…

London’s Mayor, Sadiq Khan, has officially announced today that a groundbreaking trial will kick off next Friday, 8th March.This initiative will see Tube and rail fares on pay as you go with contactless and Oyster cards set to off-peak…

The legal saga surrounding Terraform Labs co-founder Do Kwon is taking another pivotal turn as the US Securities and Exchange Commission (SEC) prepares to commence its civil trial against him on March 25, despite his likely absence…

Former Celsius CEO Alex Mashinsky has chosen to be represented by the same legal team as FTX’s Sam Bankman-Fried against allegations of wire fraud and artificially inflating the company’s token value. Bloomberg insights suggest that…

© Reuters. LOS ANGELES - Puma Biotechnology, Inc. (NASDAQ: NASDAQ:) has commenced a Phase II clinical trial to evaluate the efficacy of its drug alisertib in treating extensive stage small cell lung cancer (SCLC), the company…